Research - Basel, Basel-Stadt, Switzerland
True precision medicine through single-cell science. Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into diseases and enables ultra-sensitive diagnostics by uncovering human's hidden "single-cell" secrets. The performance and clinically-relevant application of Scailyte's platform ScaiVision have been demonstrated in numerous clinical projects that resulted in patent-pending biomarkers. Scailyte has a growing pipeline of clinical projects in immunology, oncology and women's health supported by top clinicians and access to high quality proprietary datasets.If you want to partner with us and save lives by enabling precision medicine, reach out to contact@scailyte.com More information about our company, technology & services you can find on our website - https://scailyte.com
Gmail
Google Tag Manager
Linkedin Login
Mobile Friendly
Bootstrap Framework